ATLASOvid Therapeutics (OVID) earnings date: Nov 11, 2026
Ovid Therapeutics (OVID) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026, before the open. Analysts expect EPS of -$0.08.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on OVID
| Last price | $2.54 (-0.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.2% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Ovid Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Ovid Therapeutics reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Ovid Therapeutics. You can switch it off at any time.
Alert me before OVID reportsFree to start. Creating an account takes under a minute.
OVID earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.08 |
| Last report | Aug 13, 2026 · Beat |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | +43.0% |
| Average move around a report | ±7.5% (last 4) |
| Sector | Healthcare · Biotechnology |
Ovid Therapeutics earnings history: last 4 reports
Ovid Therapeutics last reported on Aug 13, 2026: EPS of -$0.08 against an estimate of -$0.10 (+20.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.10 | -$0.08 | +20.0% | Beat | +8.0% |
| Jun 16, 2026 | $1.65 | $1.67 | +1.2% | In line | +7.1% |
| May 12, 2026 | -$0.11 | -$0.12 | -9.1% | Miss | +0.4% |
| Mar 18, 2026 | -$0.10 | $0.06 | +160.0% | Beat | +14.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for OVID
See the fair value, the probability range and the earnings history of Ovid Therapeutics on its ATLAS page.
Ovid Therapeutics (OVID) stock analysisPlans from €3.99 a month.
Ovid Therapeutics earnings: frequently asked questions
When does Ovid Therapeutics (OVID) report earnings?
Ovid Therapeutics is scheduled to report on Wednesday, November 11, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for OVID?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.08 per share (USD). Estimates can change before the report.
How often does OVID beat earnings estimates?
Of its last 4 reports with a recorded result, Ovid Therapeutics beat the EPS estimate 2 times; the average surprise was +43.0%. Past results do not predict the next one.
How much does OVID move around earnings?
Over its last 4 reports the stock moved an average of 7.5% (absolute, from the close before the report day to the close after it), and finished higher 4 of 4 times.
Did Ovid Therapeutics beat earnings estimates last quarter?
Ovid Therapeutics last reported on Aug 13, 2026: EPS of -$0.08 against an estimate of -$0.10 (+20.0% surprise), a beat.
How much does OVID usually move in a day?
On a normal trading day the ATLAS model puts OVID’s one-day range at about ±4.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer